LC-MS-MS determination of imatinib and N-desmethyl imatinib in human plasma.
Zhang Y, Qiang S, Yu Z, Zhang W, Xu Z, Yang L, Wen A, Hang T.
J Chromatogr Sci · journal article · DOI 10.1093/chromsci/bmt037 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för imatinib. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
50 träffarPrediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours.
Haouala A, Widmer N, Guidi M, Montemurro M, Leyvraz S, Buclin T, Eap CB, Decosterd LA, Csajka C.
Br J Clin Pharmacol · clinical trial; research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/j.1365-2125.2012.04422.xLong-term efficacy of imatinib for treatment of metastatic GIST.
Patel S.
Cancer Chemother Pharmacol · research support, non-u.s. gov't; review; journal article · DOI 10.1007/s00280-013-2135-8Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H.
Revheim ME, Kristian A, Malinen E, Bruland ØS, Berner JM, Holm R, Joensuu H, Seierstad T.
Acta Oncol · research support, non-u.s. gov't; research-article; journal article · DOI 10.3109/0284186x.2013.770920[Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence].
Li J, Dang YZ, Gao J, Shen L.
Zhonghua Wei Chang Wai Ke Za Zhi · journal article; english abstract[Imatinib plasma levels in the management of cutaneous side effects induced by imatinib (Glivec®): 2 case reports].
Trabelsi S, Gaïes E, Sraïri S, Sahnoun R, Daghfous R, Lakhal M, El Aïdli S, Klouz A.
Ann Biol Clin (Paris) · journal article; english abstract; case reports · DOI 10.1684/abc.2013.0795The effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Zhang FH, Ling YW, Zhai X, Zhang Y, Huang F, Fan ZP, Zhou HS, Jiang QL, Sun J, Liu QF.
Hematology · journal article · DOI 10.1179/1607845412y.0000000052Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors.
Ito T, Ogawa R, Uezumi A, Ohtani T, Watanabe Y, Tsujikawa K, Miyagoe-Suzuki Y, Takeda S, Yamamoto H, Fukada S.
Neuromuscul Disord · research support, non-u.s. gov't; journal article · DOI 10.1016/j.nmd.2012.10.025Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells.
Oh B, Kim TY, Min HJ, Kim M, Kang MS, Huh JY, Kim Y, Lee DS.
Anticancer Drugs · research support, non-u.s. gov't; journal article · DOI 10.1097/cad.0b013e32835a0fbdShould therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?
Gandia P, Arellano C, Lafont T, Huguet F, Malard L, Chatelut E.
Cancer Chemother Pharmacol · journal article · DOI 10.1007/s00280-012-2035-3Imatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia: Comparison with LC-MS/MS.
Roth O, Spreux-Varoquaux O, Bouchet S, Rousselot P, Castaigne S, Rigaudeau S, Raggueneau V, Therond P, Devillier P, Molimard M, Maneglier B.
Clin Chim Acta · comparative study; journal article · DOI 10.1016/j.cca.2009.10.007Analysis of binding energy activity of imatinib and Abl tyrosine kinase domain based on simple consideration for conformational change: An explanation for variation in imatinib effect in mutated type.
Wiwanitkit V.
Indian J Cancer · journal article · DOI 10.4103/0019-509x.55555Imatinib induces apoptosis by inhibiting PDGF- but not insulin-induced PI 3-kinase/Akt survival signaling in RGC-5 retinal ganglion cells.
Biswas SK, Zhao Y, Sandirasegarane L.
Mol Vis · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramuralInfluence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice.
Gardner ER, Smith NF, Figg WD, Sparreboom A.
J Exp Clin Cancer Res · research support, n.i.h., intramural; research-article; journal article · DOI 10.1186/1756-9966-28-99The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms.
Parkkila S, Innocenti A, Kallio H, Hilvo M, Scozzafava A, Supuran CT.
Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2009.06.002Preventive and therapeutic effects of imatinib in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis.
Iyoda M, Shibata T, Kawaguchi M, Yamaoka T, Akizawa T.
Kidney Int · research support, non-u.s. gov't; journal article · DOI 10.1038/ki.2009.43Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors.
Huang X, Patel S, Ahmed N, Seiter K, Liu D.
Drug Des Devel Ther · journal article; case-report · DOI 10.2147/dddt.s3843Dramatic and durable efficacy of imatinib in an advanced angiosarcoma without detectable KIT and PDGFRA mutations.
Kiesel H, Müller AM, Schmitt-Graeff A, Veelken H.
Cancer Biol Ther · journal article; case reports · DOI 10.4161/cbt.8.4.7547A benefit-risk assessment of imatinib in chronic myeloid leukaemia and gastrointestinal stromal tumours.
Wolf D, Rumpold H.
Drug Saf · review; journal article · DOI 10.2165/11314600-000000000-00000Imatinib-induced pseudoporphyria.
Timmer-de Mik L, Kardaun SH, Kramer MH, Hayes DP, Bousema MT.
Clin Exp Dermatol · journal article; case reports · DOI 10.1111/j.1365-2230.2008.02985.xDifferences in hematological and non-hematological toxicity during treatment with imatinib in patients with early and late chronic phase chronic myeloid leukemia.
Breccia M, Stefanizzi C, Cannella L, Latagliata R, Frustaci AM, Carmosino I, Santopietro M, Alimena G.
Leuk Lymphoma · comparative study; journal article · DOI 10.1080/10428190802578841Imatinib: a second look. Longer follow-up in chronic myeloid leukaemia: clear advantages.
Författaruppgift saknas
Prescrire Int · journal articleImatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis.
Iyoda M, Hudkins KL, Becker-Herman S, Wietecha TA, Banas MC, Guo S, Meyer-Bahlburg A, Kowalewska J, Liu G, Ziegler SF, Rawlings DJ, Alpers CE.
J Am Soc Nephrol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1681/asn.2008010036Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling.
Weigel MT, Meinhold-Heerlein I, Bauerschlag DO, Schem C, Bauer M, Jonat W, Maass N, Mundhenke C.
Cancer Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.canlet.2008.07.040Imatinib-induced tumor lysis syndrome: report of a case and review of the literature.
Chang H, Shih LY.
Chang Gung Med J · review; journal article; case reportsSuccessful use of National Cancer Registry data to monitor the effective use of imatinib for treating chronic myeloid leukaemia.
Shepherd P, Dhanapala C, Maguire C, White J, Drummond M, Holyoake T, Johnson PR.
Scott Med J · research support, non-u.s. gov't; journal article · DOI 10.1258/rsmsmj.53.3.8[Indications for pre- and postoperative treatment with imatinib for gastrointestinal stromal tumors].
Heger U, Weitz J, Lordick F.
Chirurg · review; journal article; english abstract · DOI 10.1007/s00104-008-1526-6Imatinib: new indication. New indications, but not robust evidence.
Författaruppgift saknas
Prescrire Int · journal articleSix years survival on imatinib with no disease progression after diagnosis of metastatic duodenal gastrointestinal stromal tumour: a case report.
Bhattacharya S, Choudhury AK, Ravi S, Morrissey J, Mathew G.
J Med Case Rep · research-article; journal article · DOI 10.1186/1752-1947-2-110Twin pregnancy in a patient of chronic myeloid leukemia on imatinib therapy.
Meera V, Jijina F, Shrikande M, Madkaikar M, Ghosh K.
Leuk Res · journal article; case reports · DOI 10.1016/j.leukres.2008.03.007